Energy dependence of dose and dose-rate effectiveness factor for low-let radiations: Potential importance to estimation of cancer risks and relationship to biological effectiveness

Health Physics

Volumn 93, Issue 1, 2007, Pages 17-27

  Trabalka, J R ^a   Kocher, D C ^a  

^a SENES Oak Ridge Incorporated   (United States)

Author keywords

DDREF; Radiation effects; Radiation risk; Relative biological effectiveness

Indexed keywords

CANCER RISK; ELECTRON; LINEAR ENERGY TRANSFER; MATHEMATICAL MODEL; PHOTON; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION PHYSICS; RADIOBIOLOGY; REVIEW; RISK ASSESSMENT; VALIDITY;

DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRONS; HUMANS; LINEAR ENERGY TRANSFER; MODELS, THEORETICAL; NEOPLASMS, RADIATION-INDUCED; PHOTONS; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT;

EID: 34250348639     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000255913.73300.21     Document Type: Review

References (45)

1. Bauchinger M, Schmid E, Streng S, Dresp J. Quantitative analysis of the chromosome damage at first division of human lymphocytes after 60Co γ-irradiation. Radiat Environ Biophys 22:225-229; 1983.
2. Carnes BA, Grahn D, Thompson JF. Dose response modeling of the life shortening in a retrospective analysis of the combined data from the JANUS program at Argonne National Laboratory. Radiat Res 119:39-56; 1989.
3. Committee on Interagency Radiation Research and Policy Coordination. Neutron quality factor. Washington, DC: Committee on Interagency Radiation Research and Policy Coordination; ORAU 95/F-29; 1995.
4. Cornforth MN, Bailey SM, Goodwin EH. Dose responses for chromosome aberrations produced in noncycling primary human fibroblasts by alpha particles, and by gamma rays delivered at sublimiting low dose rates. Radiat Res 158:43-53; 2002.
5. Edwards AA. Low dose and low dose rate effects in laboratory animals. Chilton, UK: National Radiological Protection Board; NRPB-TM-1-92; 1992.
6. Edwards AA. Relative biological effectiveness of neutrons for stochastic effects. Chilton, UK: National Radiological Protection Board; Doc NRPB 8(2); 1997.
7. Edwards AA. Neutron RBE values and their relationship to judgments in radiological protection. J Radiol Prot 19:93-105; 1999.
8. Frankenburg D, Kelnhofer K, Bar K, Frankenburg-Schwager M. Enhanced neoplastic transformation by mammography x rays relative to 200 kVp x rays: indication for a strong dependence on photon energy of the RBEM for various end points. Radiat Res 157:99 -105; 2002. Errata, Radiat Res 158:126; 2002.
9. Gögglemann W, Jacobsen C, Panzer W, Walsh L, Roos H, Schmid E. Re-evaluation of the RBE of 20 kV x-rays (mammography x-rays) relative to 220 kV x-rays using neoplastic transformation of human CGL1-hybrid cells. Radiat Environ Biophys 42:175-182; 2003.
10. Goodhead DT. Clustered damage to DNA: time to re-evaluate the paradigms of radiation protection? In: Moriarity M, Mothersill C, Seymour C, Edington M, Ward JF, Fry RJM, eds. Radiation research, Vol. 2. Proceedings of the eleventh international congress of radiation research. Lawrence, KS: Allen Press; 2000: 342-347.
11. Gragtmans NJ, Myers DK, Johnson JR, Jones AR, Johnson LD. Occurrence of mammary tumors in rats after exposure to tritium beta rays and 200-kVp x rays. Radiat Res 99:636-650; 1984.
12. Guerrero-Carbajal C, Edwards AA, Lloyd DC. Induction of chromosome aberration in human lymphocytes and its dependence on x ray energy. Radiat Protect Dosim 106:131-135; 2003.
13. Heyes GJ, Mill AJ. The neoplastic transformation potential of mammography x rays and atomic bomb spectrum radiation. Radiat Res 162:120-127; 2004.
14. Hill MA. The variation in biological effectiveness of x-rays and gamma rays with energy. Radiat Protect Dosim 112:471-481; 2004.
15. International Commission on Radiation Units and Measurements. The quality factor in radiation protection. Bethesda, MD: International Commission on Radiation Units and Measurements; ICRP Report 40; 1986.
16. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Report of Committee II on permissible dose for internal radiation (1959). Oxford: Pergamon Press; ICRP Publication 2; 1960.
17. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press; ICRP Publication 26; Ann ICRP 1(3); 1977.
18. International Commission on Radiological Protection. 1990 recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press; ICRP Publication 60; Ann ICRP 21(1-3); 1991.
19. R). New York: Elsevier; ICRP Publication 92; Ann ICRP 33(4); 2003.
20. International Commission on Radiological Protection. Draft recommendations of the International Commission on Radiological Protection. Stockholm, Sweden: International Commission on Radiological Protection; 2006. Available at http://www.icrp.org. Accessed 18 July 2006.
21. Kocher DC, Apostoaei AI, Hoffman FO. Radiation effectiveness factors (REFs) for use in calculating probability of causation of radiogenic cancers. Oak Ridge, TN: SENES Oak Ridge; 2002. Available at: http://www.cdc.gov/niosh/ ocas/ocasirep.html. Accessed 28 November 2005.
22. Kocher DC, Apostoaei AI, Hoffman FO. Radiation effectiveness factors for use in calculating probability of causation of radiogenic cancers. Health Phys 89:3-32; 2005.
23. Land C, Gilbert E, Smith J, Hoffman FO, Apostoaei I, Thomas B, Kocher DC. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. Bethesda, MD: National Cancer Institute; 2003.
24. Lloyd DC, Edwards AA. Chromosome aberrations in human lymphocytes: effect of radiation quality, dose and dose rate. In: Ishihara T, Sasaki MS, eds. Radiation-induced chromosome damage in man. New York: A. R. Liss; 1983: 23-49.
25. Lloyd DC, Purrott RJ, Dolphin GW, Bolton D, Edwards AA, Corp MJ. The relationship between chromosome aberrations and low-LET radiation dose to human lymphocytes. Int J Radiat Biol 28:75-90; 1975.
26. Lloyd DC, Edwards AA, Prosser JS. Chromosome aberrations induced in human lymphocytes by in vitro acute x and gamma radiation. Radiat Prot Dosim 15:83-88; 1986.
27. Loucas BD, Cornforth MN. Complex chromosome exchanges induced by gamma rays in human lymphocytes: an mFISH study. Radiat Res 155:660-671; 2001.
28. Loucas BD, Eberle R, Bailey SM, Cornforth MN. Influence of dose rate on the induction of simple and complex chromosome exchanges by gamma rays. Radiat Res 162:339-349; 2004.
29. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe G, Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM, Tirmarche M, Woodward A, Yao SX. Radon-exposed underground miners and inverse dose-rate (protraction enhancement) effects. Health Phys 69:494-500; 1995.
30. Muirhead CR, Cox R, Stather JW, MacGibbon BH, Edwards AA, Haylock RGE. Relative biological effectiveness. In: Estimates of late radiation risks to the UK population. Chilton, UK: National Radiological Protection Board; Doc NRPB 4(4); 1993: 126-139.
31. National Council on Radiation Protection and Measurements. The relative biological effectiveness of radiations of different quality. Bethesda, MD: National Council on Radiation Protection and Measurements; NCRP Report No. 104; 1990.
32. National Council on Radiation Protection and Measurements. Risk estimates for radiation protection. Bethesda, MD: National Council on Radiation Protection and Measurements; NCRP Report No. 115; 1993.
33. National Council on Radiation Protection and Measurements. Evaluation of the linear-nonthreshold dose-response model for ionizing radiation. Bethesda, MD: National Council on Radiation Protection and Measurements; NCRP Report No. 136; 2001.
34. National Research Council. Health risks from exposure to low levels of ionizing radiation. BEIR VII Phase 2. Washington, DC: The National Academies Press; 2006.
35. Regulla D, Panzer W, Schmid E, Stephan G, Harder D. Detection of elevated RBE in human lymphocytes exposed to secondary electrons released from x-irradiated metal surfaces. Radiat Res 155:744-747; 2001.
36. Schmid E, Bauchinger M, Streng S, Nahrstedt U. The effect of 220 kVp x-rays with different spectra on the dose response of chromosome aberrations in human lymphocytes. Radiat Environ Biophys 23:305-309; 1984.
37. Schmid E, Braselmann H, Nahrstedt U. Comparison of γ-ray induced dicentric yields in human lymphocytes measured by conventional analysis and FISH. Mutat Res 348:125-130; 1995.
38. Schmid E, Regulla D, Kramer H-M, Harder D. The effect of 29 kV x rays on the dose response of chromosome aberrations in human lymphocytes. Radiat Res 158:771-777; 2002.
39. Simpson PJ, Savage JR. Estimating the true frequency of x-ray-induced complex chromosome exchanges using fluorescence in situ hybridization. Int J Radiat Biol 67:37-45; 1995.
40. Straume T, Carsten AL. Tritium radiobiology and relative biological effectiveness. Health Phys 65:657-672; 1993.
41. Ullrich RL, Preston RJ. Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or γ-rays. Radiat Res 109:165-170; 1987.
42. Ullrich RL, Storer JB. Influence of γ irradiation on the development of neoplastic disease in mice. I. Reticular tissue tumors. Radiat Res 80:303-316; 1979a.
43. Ullrich RL, Storer JB. Influence of γ irradiation on the development of neoplastic disease in mice. II. Solid tumors. Radiat Res 80:317-324; 1979b.
44. Ullrich RL, Storer JB. Influence of γ irradiation on the development of neoplastic disease in mice. III. Dose-rate effects. Radiat Res 80:325-342; 1979c.
45. Upton AC, Randolph ML, Conklin JW, Kastenbaum MA, Slater M, Melville GS Jr, Conte FP, Sproul JA. Late effects of fast neutrons and gamma-rays in mice as influenced by the dose rate of irradiation: induction of neoplasia. Radiat Res 41:467-491; 1970.